TABLE 1.
Characteristics of patients enrolled in this study
| Characteristic | APS | HC |
|---|---|---|
| Number (n) | 22 | 22 |
| Age (y)* | 30 (21‐34) | 29 (21‐34)n.s. |
| Gestational weeks (wk) | 12.19 (11‐13+4) | 12.47 (11 + 13+6)n.s. |
| Clinical manifestations | ||
| Recurrent spontaneous abortions | 18 (82%) | 0 |
| Severe pre‐eclampsia | 5 (23%) | 0 |
| Unexplained stillbirth | 2 (9%) | 0 |
| Oligohydramnios | 1 (4%) | 0 |
| Foetal growth restriction | 1 (4%) | 0 |
| Lupus anticoagulant positive (% patients) | 16 (73%) | 0 |
| Anti‐β2GPI IgG | 22 (100%) | 0 |
| Anti‐β2GPI IgM | 6 (27%) | 0 |
| Anti‐cardiolipin IgG | 11 (50%) | 0 |
| Anti‐cardiolipin IgM | 4 (18%) | 0 |
Abbreviations: β2GPI, β2‐glycoprotein I;APS, antiphospholipid antibody syndrome; HC, healthy control; n.s., not significant (t test).
*
Median (range).